Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Peripheral Neuropathy and Celiac Disease.

Russell L Chin1, Norman Latov

  • 1Weill Medical College of Cornell University, Department of Neurology and Neuroscience, Peripheral Neuropathy Center, 635 Madison Avenue 4th Floor, New York, NY 10022, USA.

Current Treatment Options in Neurology
|December 22, 2004
PubMed
Summary

Peripheral neuropathy (PN) is a common neurologic issue in celiac disease (CD). While a gluten-free diet is standard, its effect on PN needs more study, and other treatments may be needed.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Time course of the autoantibody response to therapy in anti-MAG neuropathy: TWO case REPORTS.

Heliyon·2024
Same author

Anti-MAG neuropathy: historical aspects, clinical-pathological correlations, and considerations for future therapeutical trials.

Arquivos de neuro-psiquiatria·2024
Same author

Hyaluronidase-facilitated subcutaneous immunoglobulin 10% as maintenance therapy for chronic inflammatory demyelinating polyradiculoneuropathy: The ADVANCE-CIDP 1 randomized controlled trial.

Journal of the peripheral nervous system : JPNS·2023
Same author

Correction: Latov, N. <i>Campylobacter jejuni</i> Infection, Anti-Ganglioside Antibodies, and Neuropathy. <i>Microorganisms</i> 2022, <i>10</i>, 2139.

Microorganisms·2023
Same author

Intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): mechanisms of action and clinical and genetic considerations.

Expert review of neurotherapeutics·2023
Same author

<i>Campylobacter jejuni</i> Infection, Anti-Ganglioside Antibodies, and Neuropathy.

Microorganisms·2022

Area of Science:

  • Neurology
  • Immunology
  • Gastroenterology

Background:

  • Celiac disease (CD) is an autoimmune disorder triggered by gluten.
  • Peripheral neuropathy (PN) is a frequent neurologic complication of CD.
  • Common PN subtypes include sensory axonal and small fiber polyneuropathies.

Purpose of the Study:

  • To review the current understanding of celiac disease-associated peripheral neuropathy.
  • To discuss the role of gluten-free diet and potential alternative therapies.

Main Methods:

  • Review of existing literature on CD-associated PN.
  • Analysis of reported treatment outcomes for gluten-free diets and immunomodulatory agents.

Main Results:

  • A gluten-free diet is the primary therapy, but its efficacy for PN is not well-established prospectively.

Related Experiment Videos

  • Neurologic manifestations may persist independently of gluten exposure.
  • Immunomodulatory agents show promise for refractory cases.

    • Conclusions:

    • CD-associated PN management requires further investigation.
    • Gluten-free diet is foundational, but alternative or adjunctive therapies may be necessary.
    • Inflammatory processes and immunomodulatory treatments warrant consideration.